FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2964118217> ?p ?o ?g. }

• W2964118217 endingPage "e197591" @default.
• W2964118217 startingPage "e197591" @default.
• W2964118217 abstract "The US Food and Drug Administration (FDA) created the exception from informed consent (EFIC) pathway in 1996 to allow some emergency trials to enroll patients without informed consent. To protect individual autonomy and preserve public trust, the FDA requires that EFIC trial investigators consult with community members before a trial may begin.To analyze data from surveys conducted as part of community consultation ahead of EFIC trials and assess levels of public approval.All trials granted an EFIC must submit documentation of compliance with EFIC regulations to a publicly available docket at the FDA. Submissions between November 1, 1996, and October 23, 2017, were reviewed.Trials with survey data were included.Data were extracted between January 2018 and June 2018 and were analyzed between June 2018 and August 2018. The quality and validity of data were assessed according to Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. A random-effects metaregression was used to assess the association of demographic characteristics with EFIC approval.The primary study outcome was EFIC approval.The FDA docket contained 15 958 pages of material with survey data for 42 448 individuals submitted by 27 trials. Public approval of EFIC varied by question type, with more people willing to approve initiation of EFIC trials in their community (86.5%) than personal enrollment (73.0%), enrollment of a family member (68.6%), or the principle of enrollment without consent (58.4%) (P < .001 for all comparisons). In the United States, African American individuals made up 29.3% of those enrolled in EFIC trials that reported data on race (5064 of 17 302) but only 16.7% of those surveyed as part of community consultation. In the United States and Canada, men made up 42.9% of the surveyed population but 65.6% of those eventually enrolled in EFIC trials (29 961 of 45 694). Groups surveyed with higher proportions of African American and male respondents had lower rates of EFIC approval.Public approval of EFIC trials varied by question type and by the respondents' reported race and sex. The demographic characteristics of those surveyed did not match the demographic characteristics of EFIC enrollees. The FDA could strengthen community consultation by standardizing survey instruments and reporting, requiring broader inclusion of African American and male respondents, clarifying the function of surveys in the development and modification of trial protocols, and building more public consensus around the acceptable use of EFIC." @default.
• W2964118217 created "2019-07-30" @default.
• W2964118217 creator A5008017533 @default.
• W2964118217 creator A5048211823 @default.
• W2964118217 creator A5074235726 @default.
• W2964118217 creator A5074257304 @default.
• W2964118217 date "2019-07-24" @default.
• W2964118217 modified "2023-10-02" @default.
• W2964118217 title "Public Approval of Exception From Informed Consent in Emergency Clinical Trials" @default.
• W2964118217 cites W1266455795 @default.
• W2964118217 cites W1592495849 @default.
• W2964118217 cites W1967659465 @default.
• W2964118217 cites W1996802760 @default.
• W2964118217 cites W1997155295 @default.
• W2964118217 cites W1998379045 @default.
• W2964118217 cites W1999159500 @default.
• W2964118217 cites W2009028274 @default.
• W2964118217 cites W2013847400 @default.
• W2964118217 cites W2014796100 @default.
• W2964118217 cites W2032308540 @default.
• W2964118217 cites W2034629182 @default.
• W2964118217 cites W2035301974 @default.
• W2964118217 cites W2048828214 @default.
• W2964118217 cites W2058080948 @default.
• W2964118217 cites W2074330974 @default.
• W2964118217 cites W2090650515 @default.
• W2964118217 cites W2096432271 @default.
• W2964118217 cites W2097964785 @default.
• W2964118217 cites W2100700108 @default.
• W2964118217 cites W2116752647 @default.
• W2964118217 cites W2123289930 @default.
• W2964118217 cites W2123303704 @default.
• W2964118217 cites W2123665827 @default.
• W2964118217 cites W2126311058 @default.
• W2964118217 cites W2129785068 @default.
• W2964118217 cites W2132968358 @default.
• W2964118217 cites W2133226878 @default.
• W2964118217 cites W2147050304 @default.
• W2964118217 cites W2151359410 @default.
• W2964118217 cites W2152692571 @default.
• W2964118217 cites W2156098321 @default.
• W2964118217 cites W2157962981 @default.
• W2964118217 cites W2159026586 @default.
• W2964118217 cites W2162426620 @default.
• W2964118217 cites W2164315467 @default.
• W2964118217 cites W2166531273 @default.
• W2964118217 cites W2178502634 @default.
• W2964118217 cites W2255206883 @default.
• W2964118217 cites W2316419318 @default.
• W2964118217 cites W2321780818 @default.
• W2964118217 cites W2330410310 @default.
• W2964118217 cites W246286872 @default.
• W2964118217 cites W2597841823 @default.
• W2964118217 cites W2735635466 @default.
• W2964118217 cites W2765787392 @default.
• W2964118217 cites W2801081612 @default.
• W2964118217 cites W2809713819 @default.
• W2964118217 cites W2883181532 @default.
• W2964118217 cites W2888785144 @default.
• W2964118217 cites W2893238196 @default.
• W2964118217 cites W4240773735 @default.
• W2964118217 cites W4292807770 @default.
• W2964118217 cites W4294215472 @default.
• W2964118217 doi "https://doi.org/10.1001/jamanetworkopen.2019.7591" @default.
• W2964118217 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6659147" @default.
• W2964118217 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31339546" @default.
• W2964118217 hasPublicationYear "2019" @default.
• W2964118217 type Work @default.
• W2964118217 sameAs 2964118217 @default.
• W2964118217 citedByCount "19" @default.
• W2964118217 countsByYear W29641182172019 @default.
• W2964118217 countsByYear W29641182172020 @default.
• W2964118217 countsByYear W29641182172021 @default.
• W2964118217 countsByYear W29641182172022 @default.
• W2964118217 countsByYear W29641182172023 @default.
• W2964118217 crossrefType "journal-article" @default.
• W2964118217 hasAuthorship W2964118217A5008017533 @default.
• W2964118217 hasAuthorship W2964118217A5048211823 @default.
• W2964118217 hasAuthorship W2964118217A5074235726 @default.
• W2964118217 hasAuthorship W2964118217A5074257304 @default.
• W2964118217 hasBestOaLocation W29641182171 @default.
• W2964118217 hasConcept C118552586 @default.
• W2964118217 hasConcept C126322002 @default.
• W2964118217 hasConcept C127413603 @default.
• W2964118217 hasConcept C142724271 @default.
• W2964118217 hasConcept C199360897 @default.
• W2964118217 hasConcept C204787440 @default.
• W2964118217 hasConcept C2776305056 @default.
• W2964118217 hasConcept C2777106319 @default.
• W2964118217 hasConcept C41008148 @default.
• W2964118217 hasConcept C502991105 @default.
• W2964118217 hasConcept C512399662 @default.
• W2964118217 hasConcept C535046627 @default.
• W2964118217 hasConcept C56666940 @default.
• W2964118217 hasConcept C68122502 @default.
• W2964118217 hasConcept C71924100 @default.
• W2964118217 hasConcept C78519656 @default.
• W2964118217 hasConceptScore W2964118217C118552586 @default.

• next